U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets
Janssen Pharmaceuticals, Inc one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced today that the U.S. Food and Drug Administration (FDA)...
Cepheid Announces WHO Prequalification Of Xpert HIV-1 Qualitative Test
Cepheid announced that its Xpert® HIV-1 Qual test has been awarded WHO prequalification, making it one of the first molecular point of care tests...
FDA Panel To Review the Amgen’s ABP 501, Biosimilar Candidate To Adalimumab
Amgen announced that the Arthritis Advisory Committee of the U.S. FDA will review data supporting the Company's Biologics License Application (BLA) for ABP 501,...
Eisai presents data on its anti-fractalkine monoclonal antibody E6011
Eisai Co Ltd. announced that interim analyses on the latest data for the world's first anti-fractalkine monoclonal antibody E6011, discovered by Eisai's research subsidiary...
Merck, Pfizer double size of diabetes study to catch rivals
Merck in partnership with Pfizer Inc. announced that two Phase 3 studies (VERTIS Mono and VERTIS Factorial) of ertugliflozin, an investigational oral SGLT-2 inhibitor...
Dr Reddy’s drops as US agency charges firm for packaging lapses
The US CPSC, which is tasked with protecting children and families from risks of injuries or death associated with consumer products, had taken issue...
Biogen tanks as opicinumab misses Phase II endpoints in MS trial
Biogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being developed as a potential...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...